New treatment option for Hypertension, Resistant to Conventional Therapy
Official title Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension
ClinicalTrials.gov ID: NCT02057783
What this study is testing
- What it's testing
- Investigators hypothesize that CPAP treatment for suppressing OSAS in combination with a physical activity program will optimize 24-hour blood pressure control in patients with OSA-related resistant hypertension.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Patient with an obstructive sleep apnea (apnea-hypopnea index \> or equal to 15)
- Patient with resistant hypertension uncontrolled by 3 or more antihypertensive agents
- Ambulatory patient
You likely can't join if
- Acute hepatic failure, biliary cirrhosis, cholestasis
- Acute hypertension (SBP\>= 180 mmHg and/or DBP \>= 110 mmHg)
- Contraindication to CPAP treatment
The study team makes the final eligibility decision.
Where it's taking place
- Québec, Canada
- La Tronche, France
- Toulouse, France
- Geneva, Switzerland
- Lausanne, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Québec, Canada; La Tronche, France; Toulouse, France; Geneva, Switzerland; Lausanne, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.